Antonella Verrienti

2.4k total citations
74 papers, 1.8k citations indexed

About

Antonella Verrienti is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Antonella Verrienti has authored 74 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Endocrinology, Diabetes and Metabolism, 31 papers in Molecular Biology and 13 papers in Surgery. Recurrent topics in Antonella Verrienti's work include Thyroid Cancer Diagnosis and Treatment (43 papers), Neuroendocrine Tumor Research Advances (8 papers) and Thyroid Disorders and Treatments (7 papers). Antonella Verrienti is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (43 papers), Neuroendocrine Tumor Research Advances (8 papers) and Thyroid Disorders and Treatments (7 papers). Antonella Verrienti collaborates with scholars based in Italy, United States and France. Antonella Verrienti's co-authors include Cosimo Durante, Sébastiano Filetti, Marialuisa Sponziello, Diego Russo, Valeria Pecce, Giorgio Grani, Rocco Bruno, Giuseppe Damante, Elisabetta Ferretti and Efisio Puxeddu and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Antonella Verrienti

72 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonella Verrienti Italy 24 1.0k 652 363 315 310 74 1.8k
Francesca Galuppini Italy 23 383 0.4× 509 0.8× 309 0.9× 102 0.3× 362 1.2× 71 1.4k
Hans-Juergen Schulten Saudi Arabia 28 195 0.2× 764 1.2× 354 1.0× 136 0.4× 354 1.1× 91 1.9k
Bingyin Shi China 25 460 0.5× 1.1k 1.7× 190 0.5× 154 0.5× 342 1.1× 87 1.9k
Mitsuru Ono Japan 8 707 0.7× 429 0.7× 221 0.6× 264 0.8× 135 0.4× 11 1.9k
Salvatore Monti Italy 19 387 0.4× 251 0.4× 201 0.6× 172 0.5× 117 0.4× 38 1.0k
Lawrence A. Shirley United States 21 199 0.2× 525 0.8× 375 1.0× 171 0.5× 577 1.9× 48 1.5k
Babette Simon Germany 21 178 0.2× 563 0.9× 379 1.0× 505 1.6× 716 2.3× 54 1.6k
Krisztina Kisfalvi United States 14 124 0.1× 792 1.2× 352 1.0× 339 1.1× 436 1.4× 40 1.4k
Kazuyasu Nakao Japan 23 324 0.3× 609 0.9× 861 2.4× 161 0.5× 640 2.1× 91 1.8k
P Lohse Germany 27 295 0.3× 586 0.9× 450 1.2× 148 0.5× 80 0.3× 57 1.4k

Countries citing papers authored by Antonella Verrienti

Since Specialization
Citations

This map shows the geographic impact of Antonella Verrienti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonella Verrienti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonella Verrienti more than expected).

Fields of papers citing papers by Antonella Verrienti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonella Verrienti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonella Verrienti. The network helps show where Antonella Verrienti may publish in the future.

Co-authorship network of co-authors of Antonella Verrienti

This figure shows the co-authorship network connecting the top 25 collaborators of Antonella Verrienti. A scholar is included among the top collaborators of Antonella Verrienti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonella Verrienti. Antonella Verrienti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Verrienti, Antonella, Valeria Pecce, Giorgio Grani, et al.. (2024). Serum microRNA-146a-5p and microRNA-221-3p as potential clinical biomarkers for papillary thyroid carcinoma. Journal of Endocrinological Investigation. 48(3). 619–631. 2 indexed citations
2.
Tattoli, Ivan, Antonella Verrienti, Lucia Pallotta, et al.. (2024). The Interplay between Liver and Adipose Tissue in the Onset of Liver Diseases: Exploring the Role of Vitamin Deficiency. Cells. 13(19). 1631–1631. 3 indexed citations
3.
Verrienti, Antonella, Marialuisa Sponziello, Valeria Pecce, et al.. (2024). Effects of lenvatinib on glucose, cholesterol, triglycerides and estimated cardiovascular risk in patients with advanced thyroid cancer. Endocrine. 87(2). 619–626.
4.
Carbone, Antonino, et al.. (2024). Effective TRIAC treatment of a THRβ-mutated patient with thyroid hormone resistance. Endocrine. 85(2). 598–600. 1 indexed citations
5.
Ramundo, Valeria, Marialuisa Sponziello, Rosa Falcone, et al.. (2020). Low‐risk papillary thyroid microcarcinoma: Optimal management toward a more conservative approach. Journal of Surgical Oncology. 121(6). 958–963. 29 indexed citations
6.
Verrienti, Antonella, et al.. (2020). Long-term disease recurrence in the adipose tissue and striated muscles of a minimally invasive papillary thyroid carcinoma. Endocrine. 72(3). 937–939. 1 indexed citations
7.
Petti, Manuela, Daniele Bizzarri, Antonella Verrienti, Rosa Falcone, & Lorenzo Farina. (2019). Connectivity Significance for Disease Gene Prioritization in an Expanding Universe. IEEE/ACM Transactions on Computational Biology and Bioinformatics. 17(6). 2155–2161. 10 indexed citations
8.
Grani, Giorgio, Valeria Ramundo, Rosa Falcone, et al.. (2019). Thyroid Cancer Patients With No Evidence of Disease: The Need for Repeat Neck Ultrasound. The Journal of Clinical Endocrinology & Metabolism. 104(11). 4981–4989. 44 indexed citations
9.
Maranghi, Marianna, Antonio Gallo, Antonella Verrienti, et al.. (2018). A novel splicing mutation in the ABCA1 gene, causing Tangier disease and familial HDL deficiency in a large family. Biochemical and Biophysical Research Communications. 508(2). 487–493. 21 indexed citations
10.
Celano, Marilena, Catia Mio, Marialuisa Sponziello, et al.. (2017). Targeting post-translational histone modifications for the treatment of non-medullary thyroid cancer. Molecular and Cellular Endocrinology. 469. 38–47. 16 indexed citations
11.
Maggisano, Valentina, Marilena Celano, Giovanni Enrico Lombardo, et al.. (2017). Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cells. Molecular and Cellular Endocrinology. 448. 34–40. 34 indexed citations
12.
Giannetta, Elisa, Andrea M. Isidori, Cosimo Durante, et al.. (2017). Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by 18F-FDG PET/CT. Medicine. 96(6). e5621–e5621. 6 indexed citations
13.
Sponziello, Marialuisa, Antonella Verrienti, Francesca Rosignolo, et al.. (2015). PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells. Endocrine. 50(2). 434–441. 53 indexed citations
14.
Durante, Cosimo, Giovanni Tallini, Efisio Puxeddu, et al.. (2011). BRAFV600E mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas. European Journal of Endocrinology. 165(3). 455–463. 21 indexed citations
15.
Sponziello, Marialuisa, Cosimo Durante, M. D’Agostino, et al.. (2010). Growth Factor Receptors Gene Expression and Akt Phosphorylation in Benign Human Thyroid Nodules are Unaffected by Chronic Thyrotropin Suppression. Hormone and Metabolic Research. 43(1). 22–25. 12 indexed citations
16.
Sponziello, Marialuisa, Cosimo Durante, Antonella Verrienti, et al.. (2009). Regulation of sodium/iodide symporter and lactoperoxidase expression in four human breast cancer cell lines. Journal of Endocrinological Investigation. 33(1). 2–6. 14 indexed citations
17.
Torlontano, Massimo, Cosimo Durante, Isabella Torrente, et al.. (2008). TYPE 2 DEIODINASE POLYMORPHISM (THR92ALA) PREDICTS L-THYROXINE DOSE TO ACHIEVE TARGET TSH LEVELS IN THYROIDECTOMIZED PATIENTS. The Journal of Clinical Endocrinology & Metabolism. 910–913. 4 indexed citations
18.
Tiberti, Claudio, et al.. (2005). IA-2 combined epitope assay: A new, highly sensitive approach to evaluate IA-2 humoral autoimmunity in type 1 diabetes. Clinical Immunology. 115(3). 260–267. 16 indexed citations
19.
Filippi, Emanuela, Federica Sentinelli, Stefano Romeo, et al.. (2005). The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age ≤50 years). Journal of Molecular Medicine. 83(9). 711–719. 110 indexed citations
20.
Tiberti, Claudio, Fei Bao, Margherita Bonamico, et al.. (2003). Celiac disease-associated transglutaminase autoantibody target domains at diagnosis are age and sex dependent. Clinical Immunology. 109(3). 318–324. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Galuppini Breakdown of academic impact, for papers by Hans-Juergen Schulten Breakdown of academic impact, for papers by Bingyin Shi Breakdown of academic impact, for papers by Mitsuru Ono Breakdown of academic impact, for papers by Salvatore Monti Breakdown of academic impact, for papers by Lawrence A. Shirley Breakdown of academic impact, for papers by Babette Simon Breakdown of academic impact, for papers by Krisztina Kisfalvi Breakdown of academic impact, for papers by Kazuyasu Nakao Breakdown of academic impact, for papers by P Lohse
Rankless by CCL
2026